Telegraph.co.uk |
Approval Makes Xiidra The Apple Of Shire's Eye
Seeking Alpha The FDA go-ahead for Shire's (NASDAQ:SHPG) (OTCPK:SHPGF) dry eye drug Xiidra is not only a relief after a checkered path to approval, but should also help the group reduce its reliance on its ADHD franchise. Xiidra is easily the company's most valuable ... Health Highlights: July 13, 2016 BLOG: Shire's Xiidra (lifitegrast) approved Should Allergan plc Ordinary Shares Worry About Shire PLC (ADR) Win With Dry Eye Drug? |
from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNFqkoG9LTtWFCcuP_nKFYTQIT8NbA&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779156207741&ei=rXyGV5DfJM-RhQG00ZvIAw&url=http://seekingalpha.com/article/3988128-approval-makes-xiidra-apple-shires-eye
via IFTTT
No comments:
Post a Comment